Tag: Biotech

EU-Startups

In bid to improve outcomes for children with genetic bone disease, Swedish startup BOOST Pharma raises additional €3.1 million

Stockholm-based BOOST Pharma, a clinical-stage biopharmaceutical company focused on developing novel cell therapies for rare skeletal pediatric diseases, today announced that Sound Bioventures has joined its […]
November 3rd, 2025
EU-Startups

Dutch startup Source.ag raises €15.2 million to scale AI software powering 300 greenhouses across 18 countries

Source.ag, the Amsterdam-based developer of AI software for Controlled Environment Agriculture (CEA), today announced the successful close of its Series B funding round, raising €15.2 million. […]
November 3rd, 2025
EU-Startups

Spain’s Adaptam Therapeutics secures €3 million to target immune cells that help tumours evade treatment

Adaptam Therapeutics, a San Sebastian-based company pioneering cancer immunotherapies specifically targeting immunosuppressive myeloid cells, today announces the successful completion of a €3 million pre-Seed financing round […]
October 27th, 2025
EU-Startups

€10.3 million boost for Sweden’s Cellcolabs to lower global stem cell costs by 90% through scalable manufacturing

Cellcolabs, a Stockholm-based BioTech startup focused on industrial-scale production of mesenchymal stem cells (MSCs), has secured €10.3 million in new funding to support further technical development, production […]
October 27th, 2025
EU-Startups

Sweden’s Lithea secures €851k to advance tumour-targeted therapy for childhood bone cancer

Lithea, a Lund-based company working on new ways to treat cancer by delivering medicine directly into tumours, has successfully raised €851k from its current investors to […]
October 27th, 2025
EU-Startups

Sweden’s Cytely raises €3 million as labs report 75% faster analysis using its smart microscopy platform

Cytely, a Lund-based DeepTech startup, has secured €3 million in a new funding round to power the expansion of Cytely’s smart microscopy platform, which transforms standard […]
October 24th, 2025
EU-Startups

smartbax secures €4.7 million as Germany confronts 10,000 deaths a year from drug-resistant infections

smartbax, a Munich-based BioTech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the successful first closing of its €4.7 million pre-Series A financing round. […]
October 22nd, 2025
EU-Startups

Backed by €2.5 million, Hydryx targets the silent climate threat beneath Europe’s landfills

Hydryx, the Amsterdam-based ClimateTech startup tackling methane emissions from landfills, has closed a €2.5 million Seed round to accelerate its expansion into Europe – turning a […]
October 21st, 2025
EU-Startups

French startup Exeliom Biosciences boosts funding with €2.85 million to accelerate immunotherapy for cancer

Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a €2.85 million extension to its Series […]
October 21st, 2025
EU-Startups

With its notable €105 million raise, French BioTech startup Adcytherix looks to tackle cancer with novel ADC

Marseille-based Adcytherix, a biopharmaceutical company developing novel and proprietary antibody drug conjugates (ADC), has raised €105 million in a Series A financing round to advance its […]
October 16th, 2025
View more